Ivermectin for treatment against COVID-19 may become accessible without a prescription in Tennessee if legislation that passed in the Senate on April 6 is signed by Gov. Bill Lee.
As Big Tech and major retail firms move into healthcare they bring promises of convenience and innovation they claim will benefit consumers — but the move also raises questions about the ever-growing power and influence of such firms and their real motivation for getting into healthcare.
The attorney general of Texas is demanding documents from the manufacturers of puberty-blocking drugs as part of an investigation probing whether they have engaged in practices that violate state law.
Hooray for the Republican legislators in the New Hampshire House of Representatives for striking a blow for medical freedom Thursday when they voted to make it easier for people to obtain ivermectin.
Letting politicians dictate patient care, which prevents physicians from practicing medicine and saving patients’ lives, is a core problem, say Drs. Robert Malone and Peter McCullough.
Long COVID, also known as long-haul COVID, chronic COVID or long-haul syndrome, refers to symptoms that persist for four or more weeks after an initial COVID-19 infection. Board-certified internist and cardiologist Dr. Peter McCullough discusses potential treatments for long-haul COVID in the video above, including which tests may be necessary and when to seek emergency medical care.
State House of Representatives in Idaho has approved a bill to criminalize transgender treatment for minors that could be punishable by life in prison.
Repurposed drugs that have been shown to prevent or treat COVID-19 may be prescribed by physicians, the Florida Department of Health said in its new COVID-19 guidance for health care practitioners.
A family whose 21-year-old son developed a life-threatening reaction to Pfizer’s COVID vaccine has been waiting six months to learn if the U.S. government’s Countermeasures Injury Compensation Program will help cover their son’s medical bills, but there’s been no response from the program.
